ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2033

Scleritis and the Rheumatologist. Does the Type of Scleritis Help to Distinguish an Infectious Cause from an Immune Cause? Among the Immune Causes, Does It Help Differentiate Between Systemic Causes and Those Limited to the Eye?

Hanna Caroline Antunes Dos Santos1, Zoraida Sachetto1, Rodrigo da rocha jorge1, Gabriela Vilaça Gutierrez1, Renata Froes Ramos de lima1, Ananda Ribeiro Fretes1, Maria Fernanda zacarin1, Roberto dos reis1 and Alisson Pugliesi2, 1Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil, 2Unicamp, Campinas, Brazil

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Eye Disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Ophthalmologists increasingly call rheumatologists for the evaluation and treatment of scleritis. Although they can be of immune etiology (systemic or restricted to the eye), infectious causes are also possible, and sometimes recognizing them is a diagnostic challenge. Although the reasoning behind comparing uveitis and the affected eye segment is well established, little is known about whether a similar strategy can be used in the approach to scleritis.

Methods: This single-center, cross-sectional study evaluated all patients diagnosed with scleritis at a center specializing in rheumatology and ophthalmology. The diagnosis of scleritis was established on the basis of ophthalmological diagnosis, as well as its classification as non-specific anterior scleritis, posterior scleritis, diffuse anterior scleritis, anterior nodular scleritis, necrotizing anterior scleritis, and sclero-uveitis. Patients were divided and compared according to the following criteria: immune scleritis (immune-mediated scleritis of systemic etiology or immune-mediated scleritis restricted to the eye) or  infectious scleritis.
This categorization was based on an analysis of the medical records. Immune-mediated scleritis restricted to the eye was considered in patients whose rheumatological investigation did not define a systemic cause and whose infectious investigation was negative. Descriptive epidemiology, Fisher, and chi-square tests were used for statistical analysis. The R4.3.2 software was used for the statistical analyses.

Results: Between January 2023 and April 2024, 53 patients were selected as having a diagnosed with scleritis. The average age was 50,6+- 15 years-old and the predominant sex was female. Of these, 25 (48%) corresponded to systemic etiology, the main ones being RA, GPA, and RP. 21 (40,3%) patients were classified as having an immune etiology restricted to the eye and 6 (11,5%) as having infectious causes. Among the infectious causes, these were the etiologies: Bartonella sp, Pseudomonas sp, post Herpetica, Syphilis and Tuberculosis.
When comparing immune causes (systemic and restricted to the eye) with infectious causes, there were more patients with immune etiologies affecting the anterior sclera than infectious causes (80,4% vs 33,3% p: 0,028) (Table 1). When comparing immune causes, there was no difference in the type of scleritis that indicated a systemic or eye-restricted cause (Table 2).

Conclusion: In our sample, infectious causes of scleritis were in the minority (and differed from immune causes by having little preference for the anterior sclera). The type of scleritis does not seem to help distinguish a systemic cause from an immune-mediated etiology restricted to the eye, and the latter should only be considered after an extensive investigation.

Supporting image 1

Table1: Comparasion between immune or infectious ocular involvement and type of scleritis

Supporting image 2

Table2: Comparasion between systemic or restricted involvement to the eye and the type of scleritis


Disclosures: H. Caroline Antunes Dos Santos: None; Z. Sachetto: None; R. da rocha jorge: None; G. Vilaça Gutierrez: None; R. Froes Ramos de lima: None; A. Ribeiro Fretes: None; M. zacarin: None; R. dos reis: None; A. Pugliesi: None.

To cite this abstract in AMA style:

Caroline Antunes Dos Santos H, Sachetto Z, da rocha jorge R, Vilaça Gutierrez G, Froes Ramos de lima R, Ribeiro Fretes A, zacarin M, dos reis R, Pugliesi A. Scleritis and the Rheumatologist. Does the Type of Scleritis Help to Distinguish an Infectious Cause from an Immune Cause? Among the Immune Causes, Does It Help Differentiate Between Systemic Causes and Those Limited to the Eye? [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/scleritis-and-the-rheumatologist-does-the-type-of-scleritis-help-to-distinguish-an-infectious-cause-from-an-immune-cause-among-the-immune-causes-does-it-help-differentiate-between-systemic-causes-a/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/scleritis-and-the-rheumatologist-does-the-type-of-scleritis-help-to-distinguish-an-infectious-cause-from-an-immune-cause-among-the-immune-causes-does-it-help-differentiate-between-systemic-causes-a/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology